![Mark Rubinstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Rubinstein
Chief Tech/Sci/R&D Officer at
ACHIEVE LIFE SCIENCES, INC.
Net worth: 258 588 $ as of 29/06/2026
Profile
Mark L.
Rubinstein is Chief Medical Officer at Achieve Life Sciences, Inc. starting in 2025.
Formerly, Dr. Rubinstein was Head-Medical Affairs at Blip Products, Inc. Education includes a doctorate from Yale University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 27/01/2026 | 39,600 ( 0.04% ) | 258 588 $ | 29/06/2026 |
Mark Rubinstein active positions
| Companies | Position | Start |
|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 30/09/2024 |
Former positions of Mark Rubinstein
| Companies | Position | End |
|---|---|---|
Blip Products, Inc.
 Blip Products, Inc. Pharmaceuticals: MajorHealth Technology Produces and sells nicotine replacement therapy products through online | Chief Tech/Sci/R&D Officer | - |
Training of Mark Rubinstein
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
23
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
Blip Products, Inc.
Blip Products, Inc. Pharmaceuticals: MajorHealth Technology Produces and sells nicotine replacement therapy products through online | Health Technology |
- Stock Market
- Insiders
- Mark Rubinstein
